Immuneering Corporation (IMRX)
NASDAQ: IMRX
· Real-Time Price · USD
1.24
-0.05 (-3.88%)
At close: May 02, 2025, 3:59 PM
1.27
2.83%
After-hours: May 02, 2025, 05:46 PM EDT
Immuneering Revenue
Immuneering reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Immuneering generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
66
Market Cap
44.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|